These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa. Strittmatter M; Hamann GF; Strubel D; Cramer H; Schimrigk K J Neural Transm (Vienna); 1996; 103(5):591-602. PubMed ID: 8811504 [TBL] [Abstract][Full Text] [Related]
46. Milacemide effects on the temporal inter-relationship of amino acids and monoamine metabolites in rat cerebrospinal fluid. Semba J; Patsalos PN Eur J Pharmacol; 1993 Jan; 230(3):321-6. PubMed ID: 8440309 [TBL] [Abstract][Full Text] [Related]
53. Cerebrospinal monoamine metabolites and amino acid content in patients with parkinsonian syndrome and rats lesioned with MPP+. Espino A; Ambrosio S; Bartrons R; Bendahan G; Calopa M J Neural Transm Park Dis Dement Sect; 1994; 7(3):167-76. PubMed ID: 7710669 [TBL] [Abstract][Full Text] [Related]
54. Factors governing the composition of the cerebrospinal fluid. Lorenzo AV Exp Eye Res; 1977; 25 Suppl():205-28. PubMed ID: 338318 [No Abstract] [Full Text] [Related]
55. Evidence for reduced homovanillic acid (HVA) in the cerebrospinal fluid of patients with depression. Ogawa S; Kunugi H J Affect Disord; 2019 Aug; 255():. PubMed ID: 31006502 [No Abstract] [Full Text] [Related]
56. Low level of evidence for reduced homovanillic acid (HVA) in the cerebrospinal fluid of patients with depression compared to healthy non-psychiatric control individuals. Knorr U; Forman J; Pech J; Kessing LV J Affect Disord; 2019 Oct; 257():585-588. PubMed ID: 31326691 [No Abstract] [Full Text] [Related]
57. Monoamine metabolites in the cerebrospinal fluid in infantile spinal muscular atrophy. Takeuchi Y; Komatsu H; Matsuo S; Hirai K; Kawase S; Nishimura A; Sawada T Neuroreport; 1994 Apr; 5(8):898-900. PubMed ID: 8061291 [TBL] [Abstract][Full Text] [Related]
58. Analytical Method Validation for Estimation of Neurotransmitters (Biogenic Monoamines) from Cerebrospinal Fluid Using High Performance Liquid Chromatography. Lokhande RV; Bhagure GR; Dherai AJ; Naik PR; Udani VP; Desai NA; Ashavaid TF Indian J Clin Biochem; 2022 Jan; 37(1):85-92. PubMed ID: 35125697 [TBL] [Abstract][Full Text] [Related]
59. Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances revealed with a Coulochem electrode array system. Takeuchi Y; Matsushita H; Sakai H; Kawano H; Yoshimoto K; Sawada T J Child Neurol; 2000 Apr; 15(4):267-70. PubMed ID: 10805197 [TBL] [Abstract][Full Text] [Related]
60. 5-Hydroxyindoleacetic acid in cerebrospinal fluid--methodological and clinical aspects. Bertilsson L Life Sci; 1987 Aug; 41(7):821-4. PubMed ID: 2441222 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]